The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multi-gene risk signature for improved identification of cutaneous squamous cell carcinoma (cSCC) patients with a high risk of recurrence.
 
Chrysalyne Schmults
Honoraria - Regeneron
Consulting or Advisory Role - Castle Biosciences; Regeneron
Research Funding - Castle Biosciences; Genentech; Novartis; Regeneron
 
Sarah T Arron
Employment - Genentech (I)
Stock and Other Ownership Interests - Genentech (I); Pfizer (I)
Consulting or Advisory Role - Amyris/Biossance; aTyr Pharma; Castle Creek Pharmaceuticals; Gerson Lehrman Group; Pennside Partners; Zebra Medical Technologies
Research Funding - Allergan; Anacor; Genentech/Roche; LEO Pharma; Menlo Therapeutics
Patents, Royalties, Other Intellectual Property - Genentech (I)
 
Ashley Wysong
Research Funding - Castle Biosciences
 
Kyle R. Covington
Employment - Castle Biosciences; Lonza (I)
Stock and Other Ownership Interests - Castle Biosciences
 
Robert W. Cook
Employment - Castle Biosciences
Stock and Other Ownership Interests - Castle Biosciences
Research Funding - Castle Biosciences
Patents, Royalties, Other Intellectual Property - Castle Biosciences
 
Jason Newman
Consulting or Advisory Role - Castle Biosciences